Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-22-034634

Options or other derivatives

  • Director acquired 19,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Stelzer Laurie Director 2022-06-02 Grant or award · Stock Option −19,500 19,500 D: show line 1 in the form
Loading xslF345X03/doc4.xml…